Treatment of cytomegalovirus retinitis clinically resistant to ganciclovir and foscarnet with intravitreal etoposide

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 19, Issue 1, 2000, Pages 27-30

  Lüke, Christoph ^a   Bartz Schmidt, Karl U ^b   Baum, Uta E ^b   Heimann, Klaus ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; FOSCARNET; GANCICLOVIR;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; ELECTRORETINOGRAPHY; EYE TOXICITY; HUMAN; MALE; OPHTHALMOSCOPY; RETINITIS; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 17444442047     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.3109/15569520009051475     Document Type: Article

References (5)

1. J.D. Benson and E.S. Huang, Human cytomegalovirus induces expression of cellular topoisomerase II, J. Virol. 64: 9, 1990.
2. J.D. Benson, and E.S. Huang, Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: An implied role in replication of the viral genome, J. Virol. 62: 4797, 1988.
3. E.S. Huang, J.D. Benson, S.M. Huong, B. Wilson, and C. van der Horst, Irreversible inhibition of cytomegalovirus replication by topoisomerase II inhibitor, etoposide: A new strategy for the treatment of human cytomegalovirus infection, Antiviral. Res. 17: 17, 1992.
4. C. Lüke, K.U. Bartz-Schmidt, P. Walter, G. Thumann, R. Brunner, O. Michel, W. Sickel, Effects of etoposide (VP 16) on vertebrate retinal function, J. Toxicol. Cut. Ocular. Toxicol. 18 (1):23-32, 1999.
5. G.A. Peyman, D. Greenberg, and G.A. Fishman, Evaluation of toxicity of intravitreal antineoplastic drugs, Ophthalm. Surg. 15: 411, 1984.